Pharmaceuticals

Pneumococcal Vaccine Industry Anticipated to Expand at 6.1% CAGR During the Forecast Period

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Pneumococcal Vaccine Market From 2025 To 2034?

The pneumococcal vaccine market size has demonstrated significant growth over recent years. It is anticipated to increase from $8.94 billion in 2024 to $9.4 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.2%. The expansion observed in past periods is attributable to the discovery of streptococcus pneumoniae, heightened public health concern, pioneering vaccination efforts, ongoing healthcare advancements, and modifications in vaccine policy.

The pneumococcal vaccine market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $11.9 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.1%. Factors driving this growth during the forecast period include the evolution of pneumococcal strains, ongoing research and development efforts, evolving immunization priorities, broader access to vaccines, and an aging global population. Key trends anticipated during this period encompass the creation of multivalent vaccines, expanded vaccination for at-risk populations, strategies to enhance vaccine efficacy, robust education and awareness initiatives, and focused immunization for infants.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11950&type=smp

Which Factors And Drivers Are Influencing The Pneumococcal Vaccine Market In 2025?

The rising occurrence of pneumococcal infections is anticipated to boost the expansion of the pneumococcal vaccine market in the future. Pneumococcal contamination refers to any infection caused by the bacterium Streptococcus pneumoniae or pneumococcus, presenting as conditions such as pneumonia, bloodstream infections, ear infections, and sinus infections. The pneumococcal vaccine works by stimulating the body to produce antibodies against these pneumococcal bacteria, thereby reducing or eliminating disease-carrying bacteria and toxins. This process helps protect children, the elderly, and individuals with weakened immune systems from various types of pneumococcal infections. For instance, in January 2022, according to the Center for Disease Control and Prevention, a US-based public health agency, pneumococcal pneumonia is responsible for an estimated 150,000 hospitalizations annually in the United States, making up to 30% of adult community-acquired pneumonia cases. Therefore, the increasing prevalence of pneumococcal contamination is a key driver for the growth of the pneumococcal vaccine market.

What Are The Primary Types Of Segments Analyzed In The Pneumococcal Vaccine Market?

The pneumococcal vaccine market covered in this report is segmented –

1) By Product Type: Prevnar 13, Synflorix, Pneumovax23, Other Products

2) By Route of Administration: Intravenous, Intramuscular, Subcutaneous

3) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels

4) By End User: Pediatrics, Adults

Subsegments:

1) By Prevnar 13: Pediatric Formulation, Adult Formulation

2) By Synflorix: Pediatric Formulation, Adult Formulation

3) By Pneumovax23: Single-Dose Vials, Pre-Filled Syringes

4) By Other Products: PCV15 (Vaxneuvance), PCV20 (Prevnar 20), Other Regional Pneumococcal Vaccines

What Are The Latest Industry Trends Transforming The Pneumococcal Vaccine Market?

Leading companies in the pneumococcal vaccine market are developing new products to enhance their profitability. For example, in July 2023, Merck & Co Inc., a US-based pharmaceuticals company, introduced its V116 vaccine. V116 is designed to target the eight distinct serotypes of Streptococcus pneumoniae that are mainly responsible for adult pneumococcal disease. In comparison to other pneumococcal vaccines, V116 has exhibited improved immunogenicity for a range of serotypes in adult populations, and it has also generated positive immune responses in both individuals new to vaccination and those who have been previously vaccinated. The U.S. Food and Drug Administration (FDA) has granted V116 breakthrough therapy designation, and it is presently in Phase 3 development.

Who Are The Major Companies Operating In The Pneumococcal Vaccine Market?

Major companies operating in the pneumococcal vaccine market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Astellas Pharma Inc., CSL Limited, Anhui Zhifei Longcom Biopharmaceutical Co. Ltd, Serum Institute of India Private Limited, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd, Biological E Limited, Hualan Biological Engineering Inc., Beijing Minhai Biotechnology Limited Company, NPO Petrovax Pharm LLC, Vaxcyte Inc., Panacea Biotec Ltd, Inventprise LLC, Tergene Biotech Private Limited, PnuVax Incorporated, SK Bioscience Co Ltd

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report

Which Region Currently Holds The Largest Share Of The Pneumococcal Vaccine Market?

North America was the largest region in the pneumococcal vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumococcal vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pneumococcal Vaccine Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11950&type=smp

Browse Through More Reports Similar to the Global Pneumococcal Vaccine Market 2025, By The Business Research Company

Medical Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

Medical Waste Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-waste-management-global-market-report

Medical Tubing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-tubing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795